2361 — Sinohealth Holdings Income Statement

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeSmall CapNeutral

Annual income statement for Sinohealth Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	202	324	357	396	404
Cost of Revenue
Gross Profit	130	193	159	223	233
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	125	228	302	285	283
Operating Profit	77.3	96.5	54.9	111	121
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	76.1	95.5	54.5	111	120
Provision for Income Taxes
Net Income After Taxes	65.3	72	54.2	101	112
Minority Interest
Net Income Before Extraordinary Items
Net Income	67.9	78.8	55.8	102	111
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	67.9	78.8	55.8	102	111
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.149	0.208	0.135	0.239	0.27
Dividends per Share
Special Dividends per Share